Gilead Sciences, in collaboration with the Carlos III Health Institute (ISCIII), held the award ceremony for the 10th Edition of…
Alberto Hernando Calvo
Developed by VHIO investigators, VIGex is a gene expression signature that classifies solid tumors into three categories based on the…
In an invited viewpoint article published in the Cancer Discovery, co-authors Elena Garralda, Executive Director of VHIO’s Research Unit for…
